Literature DB >> 30257227

Global methylation patterns in primary plasma cell leukemia.

Katia Todoerti1, Giovanni Calice1, Stefania Trino1, Vittorio Simeon1, Marta Lionetti2, Martina Manzoni2, Sonia Fabris2, Marzia Barbieri2, Alessandra Pompa3, Luca Baldini2, Valentina Bollati4, Pietro Zoppoli1, Antonino Neri5, Pellegrino Musto6.   

Abstract

Primary plasma cell leukemia (pPCL) is a rare and very aggressive variant of multiple myeloma (MM). Specific clinical, biological and molecular patterns distinguish pPCL from MM. Here, we performed a genome-wide methylation analysis by high-density array in 14 newly diagnosed pPCL patients along with 60 MMs, and 5 patients affected by monoclonal gammopathy of uncertain significance (MGUS). Our analysis revealed a global hypomethylation profile associated with pPCL. Additionally, differential methylation patterns were found related to distinct chromosomal aberrations and DIS3 mutations, affecting genes with roles in bone metabolism, cell migration, transcription regulation or DNA damage response. When compared with MM patients, pPCL showed a distinct methylation profile mostly characterized by hypomethylated probes specific for genes involved in several processes like cell adhesion and migration. Furthermore, decreasing methylation levels were evidenced for genes significantly modulated in the progressive phases of plasma cell dyscrasias, from MGUS to MM and pPCL. Overall, our data provide new insights into the molecular characterization of pPCL, thus being potentially useful in the prognostic stratification or identification of novel molecular targets.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gene expression; Methylation; Microarray profiling; Plasma cell leukemia

Mesh:

Substances:

Year:  2018        PMID: 30257227     DOI: 10.1016/j.leukres.2018.09.007

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death.

Authors:  Debora Soncini; Paola Minetto; Claudia Martinuzzi; Pamela Becherini; Valeria Fenu; Fabio Guolo; Katia Todoerti; Giovanni Calice; Paola Contini; Maurizio Miglino; Giulia Rivoli; Sara Aquino; Alida Dominietto; Antonia Cagnetta; Mario Passalacqua; Santina Bruzzone; Alessio Nencioni; Massimo Zucchetti; Tommaso Ceruti; Antonino Neri; Roberto M Lemoli; Michele Cea
Journal:  Blood Adv       Date:  2020-09-22

Review 2.  Germline Risk Contribution to Genomic Instability in Multiple Myeloma.

Authors:  Siegfried Janz; Fenghuang Zhan; Fumou Sun; Yan Cheng; Michael Pisano; Ye Yang; Hartmut Goldschmidt; Parameswaran Hari
Journal:  Front Genet       Date:  2019-05-08       Impact factor: 4.599

3.  DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation.

Authors:  Stefania Trino; Pietro Zoppoli; Angelo Michele Carella; Ilaria Laurenzana; Alessandro Weisz; Domenico Memoli; Giovanni Calice; Francesco La Rocca; Vittorio Simeon; Lucia Savino; Luigi Del Vecchio; Pellegrino Musto; Antonella Caivano; Luciana De Luca
Journal:  Stem Cell Res Ther       Date:  2019-05-20       Impact factor: 6.832

4.  Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background.

Authors:  Elizabeta A Rojas; Luis A Corchete; María Victoria Mateos; Ramón García-Sanz; Irena Misiewicz-Krzeminska; Norma C Gutiérrez
Journal:  Blood Cancer J       Date:  2019-11-20       Impact factor: 11.037

5.  Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas.

Authors:  Valentina Condelli; Giovanni Calice; Alessandra Cassano; Michele Basso; Maria Grazia Rodriquenz; Angela Zupa; Francesca Maddalena; Fabiana Crispo; Michele Pietrafesa; Michele Aieta; Alessandro Sgambato; Giampaolo Tortora; Pietro Zoppoli; Matteo Landriscina
Journal:  Cancers (Basel)       Date:  2021-01-05       Impact factor: 6.639

6.  Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.

Authors:  Carlos Fernández de Larrea; Robert Kyle; Laura Rosiñol; Bruno Paiva; Monika Engelhardt; Saad Usmani; Jo Caers; Wilson Gonsalves; Fredrik Schjesvold; Giampaolo Merlini; Suzanne Lentzch; Enrique Ocio; Laurent Garderet; Philippe Moreau; Pieter Sonneveld; Ashraf Badros; Gösta Gahrton; Hartmut Goldschmidt; Sascha Tuchman; Hermann Einsele; Brian Durie; Baldeep Wirk; Pellegrino Musto; Patrick Hayden; Martin Kaiser; Jesús San Miguel; Joan Bladé; S Vincent Rajkumar; Maria Victoria Mateos
Journal:  Blood Cancer J       Date:  2021-12-02       Impact factor: 11.037

Review 7.  Update on primary plasma cell leukemia.

Authors:  Sung-Hoon Jung; Je-Jung Lee
Journal:  Blood Res       Date:  2022-04-30

8.  Causes of death in primary plasma cell leukemia differ from multiple myeloma: A STROBE-compliant descriptive study based on SEER database.

Authors:  Xiaoyan Ge; Weihan Meng; Wenbo Wang; Honglin Ma; Siqi Zhao; Kai Cui
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

9.  Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.

Authors:  Davine Hofste Op Bruinink; Rowan Kuiper; Mark van Duin; Tom Cupedo; Vincent H J van der Velden; Remco Hoogenboezem; Bronno van der Holt; H Berna Beverloo; Erik T Valent; Michael Vermeulen; Francesca Gay; Annemiek Broijl; Hervé Avet-Loiseau; Nikhil C Munshi; Pellegrino Musto; Philippe Moreau; Sonja Zweegman; Niels W C J van de Donk; Pieter Sonneveld
Journal:  J Clin Oncol       Date:  2022-03-31       Impact factor: 50.717

Review 10.  Genomics of Plasma Cell Leukemia.

Authors:  Elizabeta A Rojas; Norma C Gutiérrez
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.